Advertisement

Topics

Companies Related to "Oxford Therapeutics Consulting Limited" [Most Relevant Company Matches] [Advanced Search Results] RSS

13:35 EST 13th December 2017 | BioPortfolio

Here are the most relevant search results for "Oxford Therapeutics Consulting Limited" found in our extensive corporate database of over 50,000 company records.

Showing "Oxford Therapeutics Consulting Limited" Companies 1–25 of 3,100+

Extremely Relevant

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located at Milton Park, near Oxford. The company traces its roots back to Avidex Limited which was founded in 1999 as a spin-out from the University of Oxford to develop technology invented by the founder and...


Relevant

Oxford Therapeutics Consulting Limited

Consulting for the phatmaceutical and drug development.

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engagements in Healthcare IT and HIM. Oxford Healthcare Technology is a division of Oxford Global Resources, a staffing firm specializing in delivering “The Right Talent. Right Now.” ...


Isis Innovation

Isis Innovation is the technology transfer company of the University of Oxford, commercialising the research generated by University researchers and owned by the University.Isis Innovation Ltd is a wholly-owned subsidiary of the University of Oxford; it was established in 1988 and in 1997 started a major expansion phase. The University assigns its intellectual property to Isis (where there are no ...

Accelrys, Inc

The software businesses of the Oxford Molecular Group were incorporated into Accelrys Inc. on June 1, 2001.Oxford Molecular was a leading provider of cheminformatics tools. Founded in 1989, Oxford Molecular was listed on the London Stock Exchange in 1994. The Oxford Molecular Group grew aggressively through internal growth and the acquisition of software and experimentation-based companies. Acquir...

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fired, base-load scrubbed power plants under long-term coal sales contracts. As of December 31, 2009, Oxford controlled 91.6 million tons of proven and probable coal reserves, and it currently operates ...

Oxford Lasers, Inc.

Since 1977, Oxford Lasers has been supplying laser solutions to science and industry. Oxford Lasers was founded in 1977 by physicists from Oxford University whose research had been directed towards the study of new, yet practical, laser devices. Initially the company focused on the manufacture of Excimer lasers and Copper Vapor Lasers. Since 1990 it has manufactured laser-based systems incorporati...

Oxford Expression Technologies

Oxford Expression Technologies is a world-renowned centre of excellence for baculovirus protein expression. We provide protein expression products, services and consultancy to many global pharmaceutical companies and are now marketing commercial products based upon our world-beating flashBAC protein expression technologyOET was founded in 2000 by leading members of the School of Biological and Mol...

Millendo Therapeutics, Inc.

Millendo Therapeutics is focused on developing a portfolio of disease-modifying treatments for endocrine diseases caused by hormone dysregulation. Our product candidates seek to improve the quality of life for patients with orphan and specialty diseases with limited or no approved treatment options. Our clinical programs are designed to address:

e-Therapeutics plc

e-Therapeutics is an AIM-listed biotechnology company with a proprietary platform in network pharmacology, an innovative new approach to drug discovery based on the science of complex systems. The Company’s discovery activity is focused in cancer and degenerative diseases of the nervous system and its development effort on four clinical candidates spa...

Oxford Outcomes

Oxford Outcomes is an international consultancy which specialises in patient-reported outcomes, health economics, epidemiology and health programme evaluation. The company has offices in Oxford and Vancouver, as well as a new office opened in Washington D.C. in June 2006. The consultancy team isled by Diane Wild, Andrew Briggs, Adrian Levy, Maggie Tabberer, Kathy Beusterien and Mark Sculpher, supp...

Oxford Immunotec Global PLC

Oxford Immunotec Global PLC is a global, commercial-stage diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology. Its proprietary T-SPOT technology platform allows it to measure the responses of specific immune cells, known as T cells, to inform the diagnosis, prognosis and monitoring of p...

Oxford BioMedica

Oxford BioMedica advanced gene therapy techniques.

Circadian Technologies Limited

Circadian Technologies Limited is an emerging leader in the field of angiogenesis-based treatments for cancer. Focusing on a class of drug targets called Vascular Endothelial Growth Factors (VEGFs), we seek to develop truly novel therapies to extend and improve the lives of cancer sufferers. Circadians strengths are the following: Intellectual Property Circadian owns the worlds largest and mos...

Oxford Cryosystems Ltd

Oxford Cryosystems started manufacturing the Cryostream Cooler at the University of Oxford in 1985, and has placed well over 1200 Cryostreams worldwide. Oxford Cryosystems' development team is dedicated to continual improvement of the Cryostream, so that it remains the worlds most popular low temperature device for crystallography.Recently however, we have been moving away from a "one-size-fits-al...

Oxford Nanopore Technologies Ltd

Oxford Nanopore Technologies Ltd is developing a revolutionary technology for direct, electrical detection and analysis of single molecules. The platform is designed to offer market-disrupting benefits in a variety of applications.

The Oxford Knowledge Company

We began life in 1997 by providing a business information research and monitoring service to companies in hi-tech sectors such as semiconductors and biotechnology.In 1998, in response to demand from fellow tenants in the Oxford Centre for Innovation, we began to offer services in computer networking, computer technical support, and Web & email hosting. This side of the business has seen the most r...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic devices. The company was initially formed following research collaboration between Chemring and the University of Bath in 1993. The company leads the field in microwave technology ...

BioMedica Inc.

Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development of novel gene-based therapeutics with a focus on the areas of oncology and neurotherapy. The Company was established in 1995 as a spin out from Oxford University, and is listed on the London Stock Exchange.Oxford BioMedica’s products use genes as the mediators of a therapeutic effect and/or immune response...

Oxford Nanopore Technologies Ltd.

Oxford Nanopore Technologies Ltd is developing a novel technology for direct, electronic detection and analysis of single molecules using nanopores. The modular, scalable GridION technology platform is designed to offer substantial benefits in a variety of applications.

OBS Medical

OBS Medical is based in Carmel, Indiana and provides innovative clinical algorithms for safer hospitals, safer patients and safer drugs. Based on intelligent algorithms such as neural networks, data fusion and ECG waveform recognition, OBS Medical technologies cover a range of medical applications including automated early crisis warning (Visensia(R)), automated assessment of ECG waveforms includi...

Oxford Gene Technology

DNA microassays consisting of in situ synthesises oligonucleotide probes.

Oxford BioTherapeutics (OBT)

Oxford BioTherapeutics (OBT) is focused on the development of targeted antibody medicines for oncology. OBT's strategy is to develop innovative antibody-based cancer drugs, with integrated diagnostics, against novel targets that it has discovered in its unique OGAP(R) proteomic database. OBT is in an unrivalled position to convert its novel targets into a successful therapeutic pipeline throug...

PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics is an Oxford, UK-based development stage biotechnology company with a particular focus on immune therapeutics in oncology. PsiOxus has developed a patented platform for tumour-targeted delivery based on its oncolytic vaccine, enadenotucirev. Enadenotucirev’s unique design allows it to be delivered systemically via intravenous ...

Oxford Immunotec

Oxford Immunotec Ltd., the T cell measurement company, is headquartered near Oxford, UK; its US operations are based in Marlborough, MA. The company develops and sells clinical diagnostic products based on its patented T-SPOT® technology, the first FDA-approved method for directly quantifying antigen-specific T cells.


More From BioPortfolio on "Oxford Therapeutics Consulting Limited"

Quick Search
Advertisement
 

Corporate Database Quicklinks